The purpose of this study is to determine whether the early identification and more precise intervention of goal-directed intraoperative plasma volume expansion and catecholamine therapy using arterial pressure based cardiac output (APCO) measurement in addition to normal vital signs will improve postoperative organ function, in particular renal function, in patients undergoing major abdominal surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
The Control group will be assessed using the standard care of traditional vital signs
Ringers lactate, hydroxyethyl starch; norepinephrine, dobutamine
Ringers lactate, hydroxyethyl starch; norepinephrine, dobutamine
Klinikum Ludwigshafen
Ludwigshafen, RLP, Germany
The primary endpoint of the study is postoperative renal function, as determined by measurement of the glomerular filtration rate.
Time frame: 6 month
Total fluid requirements (type and volume); Drug requirement (type and volume); Other organ function (myocardial function, liver function, endothelial function, degree of inflammation)
Time frame: 6 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.